Galidesivir hydrochloride
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-18649-5 mg |
| CAS # | 222631-44-9 |
| Pricing | 5 mg, USD $2400.0 |
| Synonyms | BCX4430 hydrochloride; Immucillin-A hydrochloride |
| MWt | 301.73 |
| Formula | C₁₁H₁₆ClN₅O₃ |
| Biological Activity | Galidesivir (BCX4430) hydrochloride, an adenosine analog and a direct-acting antiviral agent, disrupts viral RNA-dependent RNA polymerase (RdRp) activity. Galidesivir hydrochloride is active in vitro against many RNA viral pathogens, including the filoviruses and emerging infectious agents such as MERS-CoV, SARS-CoV, and SARS-CoV-2. Galidesivir hydrochloride inhibits some negative-sense RNA viruses with EC50s ranging from ~3 to ~68 μM[1][2][3]. |
| Purity | 99.88% |